A study to treat mild-to-moderate COVID-19 will test a higher dose of ivermectin.
The medicine is being examined as one of three repurposed drugs in the ACTIV-6 research, which is recruiting participants with mild-to-moderate COVID-19. Repurposed drugs are ones that the FDA has previously approved for use in different medical contexts. Adrian Hernandez, M.D., the study’s administrative main investigator and executive director of the DCRI, stated, “Data…
Read More “A study to treat mild-to-moderate COVID-19 will test a higher dose of ivermectin.” »
